V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004774 | 310002128 | 1.6 | 85.999 | Not known (9) | null | 2015-05-07 | METHOTREXATE | N | null | 310023672 | PLUTO TRIAL |
| 310004775 | 310002129 | 1.62 | 62.2 | Palliative (P) | 2014-10-23 | 2014-11-05 | Doxorubicin + Ifosfamide | N | N | 310023673 | CARBOPLATIN + VINORELBINE |
| 310004777 | 310002131 | 1.73 | 84.5 | Disease modification (D) | 2015-02-06 | 2015-02-06 | Pazopanib | null | null | 310023679 | CHLVPP |
| 310004778 | 310002132 | 1.88 | 124.9 | Curative (C) | 2015-12-19 | 2015-08-29 | Cyclophosphamide High Dose | 02 | N | 310023682 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004779 | 310006900 | null | null | Disease modification (D) | 2016-08-01 | 2016-08-20 | Capecitabine (21days) + Carboplatin | N | N | 310023688 | EPIRUBICIN |
| 310004780 | 310006900 | 1.81 | 55.5 | Palliative (P) | 2016-02-21 | 2016-02-23 | BEP 3 day | 02 | N | 310023688 | DABRAFENIB + TRAMETINIB |
| 310004781 | 310006900 | 1.65 | 80.6 | Palliative (P) | 2016-07-17 | 2016-07-17 | Doxorubicin + Olaratumab | 2 | N | 310023688 | OLAPARIB |
| 310004782 | 310002133 | null | 85 | Curative (C) | 2013-06-03 | 2013-06-13 | ECarboX | N | N | 310023722 | METHOTREXATE |
| 310004783 | 310002134 | null | 65 | Curative (C) | 2014-01-02 | 2014-01-28 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | N | N | 310023746 | METHOTREXATE HIGH DOSE |
| 310004784 | 310006901 | 1.65 | 67.7 | Adjuvant (A) | 2014-04-03 | 2014-04-08 | R GCVP | 02 | N | 310023772 | FEC |
| 310004785 | 310009218 | null | 60.6 | Not known (9) | 2013-04-12 | 2013-05-05 | Cisplatin + Dacarbazine | N | N | 310023778 | CARBOPLATIN + PEMETREXED |
| 310004786 | 310009218 | 1.67 | 70.1 | Curative (C) | 2015-04-24 | 2015-04-24 | Epirubicin (weekly) | 2 | N | 310023778 | ICON8B TRIAL |
| 310004787 | 310002135 | null | 61.3 | Palliative (P) | 2016-09-07 | 2016-09-10 | FEC + DOCETAXEL | N | N | 310023781 | MITOMYCIN |
| 310004788 | 310002136 | 1.69 | null | Adjuvant (A) | null | 2016-08-09 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | null | 310023784 | RPACE-BOM |
| 310004790 | 310002138 | 1.62 | 80.3 | null | 2014-08-07 | 2014-08-19 | Carboplatin + Pemetrexed | N | N | 310023787 | CHLORAMBUCIL |
| 310004791 | 310002139 | 1.67 | 62.45 | Adjuvant (A) | 2014-07-26 | 2014-07-30 | DABRAFENIB | 02 | N | 310023798 | DHAP |
| 310004792 | 310002140 | 1.5 | 62 | Curative (C) | 2017-04-10 | 2017-04-11 | Epirubicin (weekly) | N | N | 310023799 | FEC |
| 310004793 | 310002141 | 1.7 | 61 | Palliative (P) | 2016-05-21 | 2016-05-21 | Olaparib | 2 | N | 310023808 | PREDNISOLONE + VINBLASTINE + RITUXIMAB |
| 310004794 | 310002141 | null | 83.3 | Disease modification (D) | 2011-11-15 | 2014-03-27 | Methotrexate High Dose (3g/m2) | N | N | 310023808 | CYTARABINE HIGH DOSE |
| 310004795 | 310002142 | 1.63 | 98.41 | Adjuvant (A) | null | 2017-12-21 | Doxorubicin + Olaratumab | N | null | 310023821 | DOXORUBICIN + OLARATUMAB |
| 310004796 | 310002143 | null | 83.3 | Adjuvant (A) | 2017-06-08 | 2017-06-08 | Doxorubicin + Olaratumab | 2 | N | 310023824 | IVE |
| 310004797 | 310002143 | 1.58 | null | Palliative (P) | 2015-12-24 | 2016-01-01 | Bevacizumab | 2 | N | 310023824 | PAZOPANIB |
| 310004798 | 310002143 | 1.7 | null | Palliative (P) | 2012-01-28 | 2016-10-17 | Cisplatin + Fluorouracil + RT 5day | N | N | 310023824 | TRASTUZUMAB EMTANSINE |
| 310004799 | 310002144 | 1.54 | 0 | Curative (C) | 2015-03-14 | 2015-03-31 | FLAG + Idarubicin | 02 | N | 310023832 | CARBOPLATIN + LIPOSOMAL DOX |
| 310004800 | 310002144 | 0 | 38 | Palliative (P) | 2017-12-06 | 2017-12-16 | Mitotane 2.5g | 02 | N | 310023832 | MITOTANE |
| 310004801 | 310002145 | 0 | 0 | Palliative (P) | 2015-07-15 | 2015-07-15 | BEAM | N | Y | 310023844 | AZACITIDINE |
| 310004802 | 310002146 | 1.59 | 61.6 | Adjuvant (A) | 2017-05-20 | 2017-06-04 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | Y | 310023851 | DOCETAXEL |
| 310004803 | 310002146 | 1.79 | null | Palliative (P) | null | 2015-01-27 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE | null | null | 310023851 | METHOTREXATE |
| 310004804 | 310002146 | 1.82 | 71 | Palliative (P) | 2016-03-30 | 2016-03-30 | PEG INTERFERON | 01 | N | 310023851 | ALEMTUZUMAB |
| 310004805 | 310002147 | 1.89 | 125 | Adjuvant (A) | 2014-03-03 | 2014-03-03 | PERM Trial | 02 | null | 310023877 | BEAM |
| 310004806 | 310002148 | 1.68 | null | Curative (C) | 2015-09-18 | 2015-10-02 | Chlorambucil | N | N | 310023883 | FEC |
| 310004807 | 310002149 | 1.66 | 60 | Curative (C) | 2017-08-20 | 2017-08-22 | EC | N | N | 310023897 | CETUXIMAB + RT |
| 310004808 | 310002150 | null | 91.4 | Palliative (P) | 2017-02-13 | 2017-03-04 | Docetaxel + Gemcitabine (prior RT) | 02 | null | 310023903 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310004809 | 310002151 | null | 62.2 | Palliative (P) | 2016-12-20 | 2016-12-27 | FEC 60 or 75 | null | n | 310023906 | EVEROLIMUS |
| 310004810 | 310002152 | null | 45 | Palliative (P) | 2014-01-22 | 2014-02-06 | CYCLOPHOSPHAMIDE | N | N | 310023920 | UKALL2011 |
| 310004811 | 310002153 | 1.68 | 60 | Palliative (P) | 2016-10-26 | 2016-10-27 | FEC 100 | N | N | 310023925 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 310004812 | 310002153 | 1.67 | null | null | 2013-12-07 | 2013-12-09 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 310023925 | CAPECITABINE + TEMOZOLOMIDE |
| 310004813 | 310002154 | 1.83 | 67.2 | Palliative (P) | 2013-05-03 | 2013-05-26 | CYCLOPHOSPHAMIDE | N | N | 310023927 | CYCLO + RITUXIMAB + VINCRISTINE |
| 310004814 | 310002154 | 1.66 | 99.8 | Palliative (P) | 2015-11-28 | 2015-11-28 | RITUXIMAB + prednisolone + VINBLASTINE + prednisolone | N | N | 310023927 | CVP |
| 310004815 | 310002155 | 1.71 | 52 | Palliative (P) | 2015-09-01 | 2015-09-01 | CARBOPLATIN + RT | N | N | 310023941 | BRENTUXIMAB |
| 310004816 | 310002156 | null | 75.7 | Palliative (P) | 2016-01-27 | 2016-02-03 | Etoposide oral | N | null | 310023960 | TRABECTEDIN |
| 310004817 | 310006908 | null | 86 | Palliative (P) | 2016-08-03 | 2016-08-04 | Cytarabine High Dose | N | N | 310023964 | CYTARABINE HIGH DOSE |
| 310004818 | 310006908 | 1.53 | null | Neo-adjuvant (N) | 2016-11-05 | 2016-11-05 | Bevacizumab 15mg/kg | 2 | N | 310023964 | ICON8B TRIAL |
| 310004819 | 310002157 | null | 72.5 | Adjuvant (A) | 2013-05-14 | 2013-05-17 | CAPECITABINE + CARBOPLATIN | 2 | N | 310023985 | ECHELON 1 TRIAL |
| 310004820 | 310002157 | 1.78 | 75 | null | 2017-12-27 | 2017-12-27 | PEG INTERFERON | 02 | N | 310023985 | CYCLO + ETOPOSIDE + VINCRISTINE |
| 310004821 | 310009222 | 1.85 | 65.3 | Palliative (P) | 2014-02-23 | 2014-02-23 | CARBOPLATIN + RT | N | N | 310023994 | CAPECITABINE + CARBOPLATIN |
| 310004822 | 310002158 | 1.55 | 62.4 | Palliative (P) | 2016-03-25 | 2016-04-08 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 2 | N | 310023999 | CAV |
| 310004823 | 310002159 | null | 94.45 | Curative (C) | 2013-12-15 | 2013-12-17 | Sunitinib | N | N | 310024007 | CAPECITABINE + CARBOPLATIN |
| 310004824 | 310002160 | 1.73 | 82 | Palliative (P) | 2014-01-13 | 2014-01-14 | PMitCEBO-R | 02 | null | 310024014 | CLADRIBINE |
| 310004825 | 310002161 | 1.82 | 69.8 | Curative (C) | 2016-12-23 | 2016-12-24 | DABRAFENIB | N | N | 310024026 | SELPAC TRIAL |